Senior insider sale
Chief Financial Officer at TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$513.3K
100.85K shares
What this filing means
ALAM KAMRAN plans to sell 100.85K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $513.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/23/2026ACC: 0001793412-26-000006
Officer· Chief Financial Officer
Since Sep 2020
100.85K
Shares to sell
$513.3K
Approx. market value
100.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
1/23/2026
100.85KTotal acquired100.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 100.85K | — |
| Total | 100.85K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
100.85K
Market value
$513.3K
1/23/2026
Total
Units
100.85K
Value
$513.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/23/2026 | 100.85K | $513.3K | Nasdaq | Planned |
| Total | 100.85K | $513.3K | ||